血小板激活因子在血液溶解性尿血病综合征的尿液分泌
A Benigni1, P Boccardo, M Noris
1Division of Nephrology, Ospedali Riuniti Bergamo, Italy.
Lancet (London, England)
|April 4, 1992
概括
尿中血小板激活因子 (PAF) 在急性阶段在患有血溶性尿素性综合征 (HUS) 的儿童中显著较高. 康复后尿中PAF水平下降,这表明它可能表明HUS疾病活性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 儿科 儿科 儿科
- 免疫学 免疫学 免疫学
背景情况:
- 溶血性尿素性综合征 (HUS) 涉及血小板激活和球损伤.
- 血小板激活因子 (PAF) 参与HUS的发病.
- 在HUS患者中,尿路PAF分泌尚未得到广泛研究.
研究的目的:
- 在患有HUS的儿童中检查尿液PAF水平.
- 为了确定尿液PAF是否与HUS疾病活动相关.
主要方法:
- 放射性免疫测试用于测量尿液中PAF度.
- 研究了10名患有HUS的儿童和10名健康对照.
- 在急性HUS期间和康复后收集尿样.
主要成果:
- 与对照组相比,急性期HUS患者的尿液PAF度显著更高 (2.04vs0.72 ng/mg肌,p<0.05).
- 康复的HUS患者的尿液PAF水平与对照水平相似.
- 在急性HUS期间尿路PAF升高可能表明血小板激活和球损伤.
结论:
- 在儿童中,尿路PAF在HUS急性阶段显著升高.
- 尿路PAF可能作为HUS疾病活动的潜在生物标志物.
- 需要进一步的研究来探索PAF在HUS病理生理学中的作用.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...


